Medpace

This space will be dedicated to Medpace experts addressing the most pressing topics that are currently facing the clinical development industry.

Medpace celebrated 25 years as a global CRO at the DIA 2017 Annual Meeting, at Booth #1118.

Dr. Eagleton discusses strategies for using rare disease research networks to accelerate drug development.

Topic: Source Control Review in Clinical Trials of Anti-infective Agents in Complicated Intra-abdominal Infections. Read Now.

As part of one of the world's leading CROs, Medpace employees are truly making a difference in the lives of patients around the globe.

Medpace’s mission is to accelerate the development of safe and effective medical therapeutics through the advancement of clinical research.

The company offers clinical trial outsourcing through a single-vendor strategy and CRO services supported by wholly-owned Central Laboratories, Bioanalytical Lab, Imaging Core Lab, ECG Core Lab, a Phase I Unit, and a Clinical Trial Management System.

Medpace is a global full-service clinical research organization with office locations across six continents. The page provides information about each lab and contact details.

Medpace is a CRO with more than 30 years of organic growth, offering clinical development services focused on consistent growth and stable service.

For detailed inquiries, feedback, or comments, please click the relevant item below.

The page provides a Request for Information form for drug and medical device sponsors, and a Medpace representative will follow up.

The page provides a form for pharmaceutical and medical device sponsors, and a representative will follow up.

Medpace is a scientifically-driven, global, full-service contract research organization providing Phase I-IV clinical development services.

EFFECTIVE OCTOBER 22, 2025 1. Introduction 1.1 This policy applies to all information relating to any identified or identifiable natural person. An